ニュース
After surviving brain surgery, I found clarity, strength, and unexpected joy; facing my fears became the turning point, not ...
After brain surgery for a malignant tumor, I faced fears, found strength, and embraced living in the moment as I begin ...
There is an urgent need for more inclusive and community-focused cancer clinical trials, according to Kimberly (Cary) ...
New clinical trials are advancing treatments for cutaneous T-cell lymphoma, advanced solid tumors, pediatric sarcomas and ALK ...
Food insecurity significantly increases the risk of death among cancer survivors, according to research published by Penn ...
Doptelet and new oral sprinkle granules is approved for children one year and older with chronic immune thrombocytopenia, ...
Barbera credits Dr. Donna Klobocista’s compassionate guidance before surgery for giving her confidence; now she mentors ...
CURE®s’ news page brings patients, survivors, and caregivers everything they need to know when it comes to cancer news and important oncology updates.
Spencer, Assistant Editor of CURE®, has been with MJH Life Sciences since 2024. A graduate of Rowan University with a bachelor's degree in health communication, Spencer enjoys spending time with ...
A dual cancer diagnosis rewired how I live, love, and show up in the world — with presence, purpose, and unapologetic passion ...
Dr. Weijing Sun discussed how GIST is typically diagnosed, as well as what tests are commonly used to confirm the diagnosis.
Fotivda preserved quality-of-life scores in kidney cancer, with better outcomes in second-line use and no added benefit from combining with Opdivo.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する